FDA approves first drug for Thymidine Kinase 2 Deficiency: All we know about this very rare mitochondrial disease

A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...

Reimagining biocatalysis: Turning DNA phosphates into chiral catalysts

Chemists at the National University of Singapore (NUS) have found a new use for deoxyribonucleic acid (DNA), not just as ...
Nature

‘Biotech Barbie’ says the time has come to consider CRISPR babies. Do scientists agree?

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Spiders inspire biologists to create artificial webs to capture airborne DNA for biodiversity monitoring

The global crisis of diminishing biological diversity is challenging our current ability to monitor changes in ecosystems.
Morning Overview on MSN

Genes pick up DNA that could save species from dying out

Recent research has uncovered a fascinating mechanism in the nematode worm C. elegans that could have profound implications ...